Picture of Lakefront Biotherapeutics NV logo

LKFT Lakefront Biotherapeutics NV News Story

0.000.00%
nl flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Galapagos NV Says FY Operating Loss EUR 188.3 Million

Feb 12 (Reuters) - Galapagos NV  GLPG.AS :
    * GALAPAGOS NV - FY OPERATING LOSS EUR 188.3 MILLION
    * GALAPAGOS NV -  EXPECTS ITS NORMALIZED ANNUAL CASH BURN TO
BE
BETWEEN EUR 175 MILLION AND EUR 225 MILLION, EXCLUDING
RESTRUCTURING COSTS
    * GALAPAGOS NV - FY NET LOSS FROM CONTINUING OPERATIONS EUR
1.3
MILLION
    * GALAPAGOS NV - UPON SEPARATION, GALAPAGOS EXPECTS TO HAVE
APPROXIMATELY EUR 500 MILLION IN CASH TO ACCELERATE ITS PIPELINE
AND FUND ITS OPERATIONS TO 2028

Source text:  ID:nGNEbY80Rg 
Further company coverage:  GLPG.AS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lakefront Biotherapeutics NV

See all news